Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid.
D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000494:pharmacology*; D001681:Biological Assay; D004347:Drug Interactions; D005260:Female; D006207:Half-Life; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D012294:Rifamycins / Q000097:blood* / Q000494:pharmacology; D012505:Sarcina / Q000187:drug effects; D012737:Sex Factors; D013223:Statistics as Topic; D013997:Time Factors; D014376:Tuberculosis / Q000097:blood
D000636:Aminosalicylic Acids; D012294:Rifamycins; D007538:Isoniazid